Tower Research Capital (TRC)’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,997
| Closed | -$1.59K | – | 5693 |
|
|
2025
Q1 | $1.59K | Buy |
+2,997
| New | +$1.59K | ﹤0.01% | 4687 |
|
|
2024
Q4 | – | Sell |
-349
| Closed | -$5K | – | 6098 |
|
|
2024
Q3 | $5K | Sell |
349
-46
| -12% | -$660 | ﹤0.01% | 4345 |
|
|
2024
Q2 | $6.4K | Buy |
395
+168
| +74% | +$2.72K | ﹤0.01% | 4585 |
|
|
2024
Q1 | $23K | Sell |
227
-40
| -15% | -$4.05K | ﹤0.01% | 2877 |
|
|
2023
Q4 | $6.31K | Sell |
267
-92
| -26% | -$2.18K | ﹤0.01% | 4760 |
|
|
2023
Q3 | $7.25K | Buy |
359
+150
| +72% | +$3.03K | ﹤0.01% | 4488 |
|
|
2023
Q2 | $5.42K | Buy |
209
+61
| +41% | +$1.58K | ﹤0.01% | 4807 |
|
|
2023
Q1 | $3K | Buy |
148
+15
| +11% | +$304 | ﹤0.01% | 5264 |
|
|
2022
Q4 | $3K | Buy |
133
+131
| +6,550% | +$2.96K | ﹤0.01% | 5261 |
|
|
2022
Q3 | $0 | Sell |
2
-336
| -99% | – | ﹤0.01% | 6585 |
|
|
2022
Q2 | $9K | Buy |
338
+215
| +175% | +$5.73K | ﹤0.01% | 4604 |
|
|
2022
Q1 | $10K | Buy |
123
+63
| +105% | +$5.12K | ﹤0.01% | 4372 |
|
|
2021
Q4 | $12K | Buy |
60
+29
| +94% | +$5.8K | ﹤0.01% | 4345 |
|
|
2021
Q3 | $10K | Buy |
31
+29
| +1,450% | +$9.36K | ﹤0.01% | 4351 |
|
|
2021
Q2 | $0 | Sell |
2
-6
| -75% | – | ﹤0.01% | 5930 |
|
|
2021
Q1 | $3K | Buy |
+8
| New | +$3K | ﹤0.01% | 4941 |
|